OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

PHARMING GRP EO-,01/  NL0010391025  /

Düsseldorf
10/8/2024  8:11:01 AM Chg. +0.020 Volume Bid7:50:04 PM Ask7:50:04 PM High Low
0.749EUR +2.75% 0
Turnover: 0.000		 -Bid Size: - -Ask Size: - 0.749 0.749
GlobeNewswire 8/1 Pharming Group reports second quarter and first half 2024 financial results and provides business up...
GlobeNewswire 7/18 Pharming Group to report second quarter and first half 2024 financial results on August 1
GlobeNewswire 6/3 Pharming Group to participate in June investor conferences
GlobeNewswire 5/21 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
GlobeNewswire 5/20 Pharming Group to participate in May investor conference
GlobeNewswire 5/8 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 4/24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 4/8 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 4/3 Pharming Group to participate in April investor conferences
GlobeNewswire 3/14 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 2/29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 2/8 Pharming Group to participate in February investor conferences
GlobeNewswire 1/8 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 12/13/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 11/21/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 11/1/2023 Pharming Group to participate in November investor conferences
GlobeNewswire 10/26/2023 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 10/12/2023 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 9/25/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 3/6/2014 Pharming Reports On Preliminary Financial Results 2013
GlobeNewswire 2/24/2014 PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®
GlobeNewswire 11/8/2013 PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST
GlobeNewswire 11/7/2013 Pharming Reports On Financial Results For The First Nine Months Of 2013
GlobeNewswire 10/9/2013 Pharming announces €12.0 million private equity placement with institutional investors
GlobeNewswire 8/29/2013 Pharming redeems final tranche of convertible bond for cash